Pfizer News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Orderbuch			Analysen
Historisch

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Orderbuch

Analysen

Historisch

20.10.23	FDA Approves PENBRAYA™, the First and Only Vaccine for the Prevention of the Five Most Common Serogroups Causing Meningococcal Disease in Adolescents (Businesswire)
16.10.23	Everest Medicines' Licensing Partner Pfizer Announces U.S. FDA Approves Etrasimod for Adults with Moderately to Severely Active Ulcerative Colitis (PR Newswire)
16.10.23	Astellas to Share New Data Across Hard-to-Treat Cancers During ESMO Congress 2023 (PR Newswire)
13.10.23	Pfizer Amends U.S. Government Paxlovid Supply Agreement and Updates Full-Year 2023 Guidance (Businesswire)
13.10.23	Pfizer Says FDA Approves VELSIPITY For Adults With Moderately To Severely Active Ulcerative Colitis (RTTNews)
12.10.23	Pfizer: FDA Approves BRAFTOVI + MEKTOVI In Treatment Of Metastatic NSCLC With BRAF V600E Mutation (RTTNews)
12.10.23	U.S. FDA Approves Pfizer’s BRAFTOVI® + MEKTOVI® for BRAF V600E-Mutant Metastatic Non-Small Cell Lung Cancer (Businesswire)
05.10.23	Pfizer Presents New Data at IDWeek 2023 Highlighting Advances in Prevention and Treatment of Certain Respiratory Illnesses and Other Infectious Diseases (Businesswire)
04.10.23	Pfizer Declares Fourth-Quarter 2023 Dividend (Businesswire)
03.10.23	Pfizer's Hospira Recalls Sodium Bicarbonate, Lidocaine HCl Injections (RTTNews)
27.09.23	Ginkgo Bioworks Announces Multi-Target RNA Discovery Collaboration with Pfizer (PR Newswire)
26.09.23	Pfizer Plant In North Carolina Restarts Production After Tornado Damage (RTTNews)
23.09.23	CDC Recommends Pfizer's Vaccine 'Abrysvo' To Help Protect Babies Against Severe RSV Illness (RTTNews)
22.09.23	Pfizer Broadens Portfolio of Respiratory Vaccines Recommended by CDC Advisory Committee with ABRYSVO™ for RSV (Businesswire)
19.09.23	Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference (Businesswire)
19.09.23	Pfizer's LITFULO To Treat Severe Alopecia Areata Gets Approval In EU (RTTNews)
19.09.23	GSK : EC Authorizes ViiV Healthcare's Apretude For HIV Prevention (RTTNews)
19.09.23	European Commission Approves Pfizer’s LITFULO™ for Adolescents and Adults With Severe Alopecia Areata (Businesswire)
18.09.23	Pfizer Invites Public to View and Listen to Webcast of October 31 Conference Call with Analysts (Businesswire)
13.09.23	CDC Recommends Updated Pfizer, Moderna COVID-19 Vaccine (RTTNews)
13.09.23	European Medicines Agency Validates Type II Variation for Astellas' XTANDI® (enzalutamide) for Treatment of Non-Metastatic Hormone-Sensitive Prostate Cancer with High-Risk Biochemical Recurrence (PR Newswire)
12.09.23	Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference (Businesswire)
12.09.23	FDA Approves Pfizer-BioNTech's Updated COVID-19 Vaccine (RTTNews)
11.09.23	Pfizer and BioNTech Receive U.S. FDA Approval for 2023-2024 COVID-19 Vaccine (Businesswire)
05.09.23	Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference (Businesswire)
30.08.23	Pfizer, BioNTech Obtain Positive CHMP Opinion For Omicron XBB.1.5-adapted COVID-19 Vaccine In EU (RTTNews)
30.08.23	Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron XBB.1.5-adapted COVID-19 Vaccine in the European Union (Businesswire)
30.08.23	Pfizer Invites Public to View and Listen to Two Webcasts of Pfizer Discussions at Healthcare Conferences (Businesswire)
25.08.23	EU Approves Pfizer' Abrysvo To Help Protect Infants And Older Adults From RSV (RTTNews)
24.08.23	European Commission Approves Pfizer’s ABRYSVO™ to Help Protect Infants through Maternal Immunization and Older Adults from RSV (Businesswire)
24.08.23	Everest Medicines Announces Interim Results for First Half of 2023 (PR Newswire)
23.08.23	Pfizer, Astellas' XTANDI Gets Priority Review In Non-metastatic Castration-sensitive Prostate Cancer (RTTNews)
23.08.23	FDA Grants Priority Review for XTANDI® in Non-Metastatic Castration-Sensitive Prostate Cancer with High-Risk Biochemical Recurrence (PR Newswire)
22.08.23	FDA Approves Pfizer's Abrysvo For Pregnant Individuals To Prevent RSV In Infants (RTTNews)
21.08.23	U.S. FDA Approves ABRYSVO™, Pfizer’s Vaccine for the Prevention of Respiratory Syncytial Virus (RSV) in Infants Through Active Immunization of Pregnant Individuals 32-36 Weeks of Gestational Age (Businesswire)
14.08.23	Pfizer’s ELREXFIO™ Receives U.S. FDA Accelerated Approval for Relapsed or Refractory Multiple Myeloma (Businesswire)
04.08.23	Pfizer Faces Distribution Restrictions Following Tornado Damage To North Carolina Plant (RTTNews)
01.08.23	Pfizer Reaffirms FY23 Adj. EPS Outlook - Update (RTTNews)
01.08.23	Pfizer Inc. Q2 Profit Decreases, but beats estimates (RTTNews)
01.08.23	Pfizer Reports Second-Quarter 2023 Results (Businesswire)
31.07.23	Biotech Stocks Facing FDA Decision In August 2023 (RTTNews)
28.07.23	AstraZeneca Q2 Profit Surges, Signs Gene Therapy Deal With Pfizer; Stock Up (RTTNews)
27.07.23	Pfizer Announces Executive Leadership to Advance Oncology Research and Development Strategy (Businesswire)
21.07.23	Pfizer Announces Post-Tornado Relief Plans for Rocky Mount Community and Manufacturing Facility (Businesswire)
19.07.23	Pfizer Announces New England Journal of Medicine Publication on Group B Streptococcus (GBS) Maternal Vaccine Candidate (Businesswire)
18.07.23	Flagship Pioneering, Pfizer Partner To Develop Innovative Medicines (RTTNews)
18.07.23	Flagship Pioneering and Pfizer Partner to Accelerate Development of Innovative Medicines Targeting Unmet Needs (PR Newswire)
06.07.23	Caribou Gains In Pre-market After Getting $25 Mln Equity Investment From Pfizer (RTTNews)
28.06.23	Pfizer Says Its NGENLA Gets FDA Approval To Treat Pediatric Growth Hormone Deficiency (RTTNews)
28.06.23	FDA Approves Pfizer’s NGENLA™, a Long-Acting Once-Weekly Treatment for Pediatric Growth Hormone Deficiency (Businesswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Part Grp Hldg	1’263.50	2.89 %	K V
Sonova Hldg	312.10	2.66 %	K V
Novartis	93.68	2.32 %	K V
Geberit	526.80	1.97 %	K V
Roche Hldg G	254.30	1.27 %	K V
Kuehne+Nagel Int	209.50	0.72 %	K V
UBS Group	28.30	0.57 %	K V
Givaudan	3’933.00	0.36 %	K V
Nestle	76.00	0.05 %	K V
Lonza Grp	521.40	-0.04 %	K V

mehr

22.11.24		Dow Jones aktuell: Dow Jones zum Ende des Freitagshandels in der Gewinnzone
22.11.24		Freundlicher Handel in New York: Dow Jones präsentiert sich am Freitagnachmittag fester
22.11.24		Börse New York in Grün: Dow Jones bewegt sich am Mittag im Plus
22.11.24		Zuversicht in London: FTSE 100 beendet die Freitagssitzung in der Gewinnzone
22.11.24		Gute Stimmung in Europa: Anleger lassen STOXX 50 letztendlich steigen
22.11.24		Handel in Frankfurt: TecDAX letztendlich in Grün
22.11.24		Freundlicher Handel: Börsianer lassen SPI schlussendlich steigen

22.11.24

Dow Jones aktuell: Dow Jones zum Ende des Freitagshandels in der Gewinnzone

22.11.24

Freundlicher Handel in New York: Dow Jones präsentiert sich am Freitagnachmittag fester

22.11.24

Börse New York in Grün: Dow Jones bewegt sich am Mittag im Plus

22.11.24

Zuversicht in London: FTSE 100 beendet die Freitagssitzung in der Gewinnzone

22.11.24

Gute Stimmung in Europa: Anleger lassen STOXX 50 letztendlich steigen

22.11.24

Handel in Frankfurt: TecDAX letztendlich in Grün